These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35536535)

  • 21. Primary aldosteronism and pregnancy.
    Morton A
    Pregnancy Hypertens; 2015 Oct; 5(4):259-62. PubMed ID: 26597737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in the diagnosis and treatment of primary aldosteronism.
    Yoshida Y; Shibata H
    Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
    Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
    Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
    Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary aldosteronism: diagnostic and therapeutic considerations.
    Nishizaka MK; Calhoun DA
    Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of successful outcome in patients with primary aldosteronism.
    Moo TA; Zarnegar R; Duh QY
    Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
    Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
    Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.
    Parra Ramírez P; Martín Rojas-Marcos P; Paja Fano M; González-Boillos M; Pascual-Corrales E; García Cano AM; Ruiz-Sanchez JG; Vicente Delgado A; Gómez Hoyos E; Ferreira R; García Sanz I; Recasens Sala M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; Rebollo Román Á; Robles Lázaro C; Morales-Ruiz M; Calatayud M; Andree Furio Collao S; Meneses D; Sampedro-Nuñez MA; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano Gotarredona J; Michalopoulou Alevras T; Tenés Rodrigo S; Roa Chamorro R; Jaen Aguila F; Moya Mateo EM; Hanzu FA; Araujo-Castro M
    High Blood Press Cardiovasc Prev; 2024 Jan; 31(1):43-53. PubMed ID: 38225508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary aldosteronism: analysis of a series of 54 patients].
    Sabio JM; Mediavilla-García JD; Jaén F; Fernández-Torres C; Aliaga L; Jiménez-Alonso J
    Med Clin (Barc); 2005 May; 124(20):765-8. PubMed ID: 15927101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized Treatment of Patients With Primary Aldosteronism.
    Obeid H; Chen Cardenas SM; Khairi S; Turcu AF
    Endocr Pract; 2023 Jun; 29(6):484-490. PubMed ID: 36273684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
    Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
    Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The difficulties in differential diagnosis of primary aldosteronism subtypes in women with strokes at a young age].
    Bohdanowicz-Pawlak A; Szymczak J; Jakubowska J; Brona A
    Endokrynol Pol; 2009; 60(6):492-6. PubMed ID: 20041369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of primary aldosteronism: Where are we now?
    Karagiannis A
    Rev Endocr Metab Disord; 2011 Mar; 12(1):15-20. PubMed ID: 21305359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Patient with Bilateral Primary Aldosteronism Refractory to Oral Eplerenone Who Responded to Esaxerenone with Increased Renin Activity.
    Okamura K; Matsushima M; Yamamoto F; Takamiya Y; Okuda T; Shirai K; Okamura K; Urata H
    Am J Case Rep; 2020 Jan; 21():e920615. PubMed ID: 31907345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
    Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
    J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.